The largest database of trusted experimental protocols

41 protocols using live dead fixable violet

1

Isolation and Analysis of Murine Muscle Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both TA muscles from 1 mouse were pooled, finely minced, and digested for 60 minutes at 37°C for in Hanks’ balanced salt solution lacking calcium and magnesium (HBSS–/–, Thermo Fisher Scientific), supplemented with 250 U/mL collagenase II (Thermo Fisher Scientific), 4.0 U/mL dispase (MilliporeSigma), and 2.5 mmol/L CaCl2 (MilliporeSigma). The resulting digest solution was filtered through a 40 μm cell strainer and centrifuged at 350g for 5 minutes. Cells were Fc blocked with a CD16/CD32 antibody (Thermo Fisher Scientific, 14-0161-82) for 10 minutes at 4°C and then incubated for 30 minutes on ice with primary antibodies, including including CD45-PE (30-F11) (Thermo Fisher Scientific, 12-0451-82), Ly-6G-FITC (1A8) (BD Pharmingen, 551460), CD64-APC (X54-5/7.1) (BioLegend, 139306, CD11c-APCe780 (N418) (BioLegend, 47-0114-80), and Live/Dead fixable violet (Thermo Fisher Scientific, L34963). Flow cytometry was performed using LSRFortessa cell analyzer (BD Biosciences) and data were analyzed with FlowJo software.
+ Open protocol
+ Expand
2

Quantifying Intracellular ROS in Myeloid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ly6C+ cells were isolated from in vitro moDC and M-MDSC cultures and plated at 6x104 cells per well in a 96 nonpyrogenic flat bottom plate where some wells were coated with active CD47 protein. In certain conditions, cells were pre-treated with anti-SIRPα blocking antibody as described above. The cells were incubated for 4h in GM-CSF alone, GM-CSF-TCM, GM-CSF-TCM-activeCD47 or anti-SIRPα-GM-CSF-TCM-activeCD47. After incubation, cells were washed and treated with 10μM 2′,7′-Dichlorodihydrofluorescein diacetate (DCFDA; Sigma-Aldrich) in basal DMEM for 25min. Immediately after, cells were washed twice with PBS and transferred to ice. Then, they were resuspended in PBS with Live/Dead Fixable Violet (Thermo, Cat: 62248) viability dye, diluted 1:1000, for 3min, to label dead cells. Samples were Immediately washed once with PBS and run on an LSR Fortessa cell analyzer (BD, Biosciences) to measure DCFDA levels as a readout for intracellular ROS.
+ Open protocol
+ Expand
3

CD8+ T Cell Cytolytic Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
P815 mastocytoma target cells were labeled with LIVE/DEAD Fixable Violet (Thermo Fisher Scientific) and TFL4 (OncoImmun), washed twice in PBS, and incubated for 30 min at room temperature with α-CD3 (1 μg/mL; clone UCHT1; Bio-Rad). CD8+ T cells were negatively selected from blood and TDL using a CD8+ T Cell Enrichment Kit (StemCell Technologies). Isolated CD8+ T cells were rested in complete medium for at least 45 min at 37°C and then incubated with α-CD3-coated P815 cells at different E:T ratios in a 96-well V-bottom plate for 4 hr at 37°C. Cells were then stained with α-active caspase-3–FITC (clone C92–605; BD Biosciences) and α-CD3–PE (clone SK7; BD Biosciences) and acquired using an LSRII (BD Biosciences). Cytolytic activity was calculated by subtracting the frequency of active caspase-3+TFL4+LIVE/DEAD P815 cells in target-only wells from the frequency of active caspase-3+TFL4+LIVE/DEAD P815 cells in wells containing CD8+ T cells.
+ Open protocol
+ Expand
4

Multicolor Flow Cytometry Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were resuspended in PBS with Live/Dead Fixable Violet (Thermo, Cat: 62248) viability dye, diluted 1:1000, for 15min. After washing, samples were incubated with fluorophore-conjugated primary antibodies prepared at 1:300 dilution in FACS buffer (0.5% BSA in PBS) and mixed 1:1 with Fc block (generated in house from a rat 2.4G2 hybridoma cell line)), for 40min, at 4°C. After surface staining, and if intracellular epitope detection was required, samples were fixed, permeabilised and stained in accordance with the FoxP3/ Transcription Factor Staining Kit (eBioscience, Cat: 00- 5523). Briefly, cells were incubated with fluorophore-conjugated primary antibodies, diluted 1:300 in permeabilization buffer, for 30min at RT. After washing, samples were run on an LSR Fortessa cell analyzer (BD Biosciences) and analysed using FlowJo version 10. (FlowJo, BD Biosciences).
+ Open protocol
+ Expand
5

Flow Cytometry Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric analyses were performed using the 13-color CytoFLEX S (Beckman Coulter) instrument to acquire data. Data were analyzed using FlowJo v10.8 (Becton Dickenson and Company). DAPI (0.5 mg/mL, Thermo Fisher Scientific, cat. no. D1306) or a live/dead fixable violet (Thermo Fisher Scientific, cat. no. L34964) was used to exclude dead cells in all experiments. Antibodies to the murine and human proteins used for flow cytometry are listed in Supplementary Table S1.
+ Open protocol
+ Expand
6

Dual Fluorescent Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FUW mCherry-GFP-LC3 reporter plasmid was obtained from Addgene (Plasmid #110060) which was utilized to generate lentivirus in 293 T cells. B16-F10 Cas9-expressing cells were then infected and grown for 48 h. Cells were then plated and treated with standard DMEM with 10% FBS or Hanks Balanced Salt Solution for the indicated time. Following the time course all cells were washed 3x with PBS and then resuspended in 100 uL of PBS and stained with LIVE/DEAD Fixable Violet (ThermoFisher L34955) stain per the manufacturer’s instructions.
Cells were then passed through a 40-micron filter to generate a single cell suspension and then run on a BD FACSCelesta. Single cells were gated for live cells and then the individual GFP and mCherry signal were measured in the FITC and CF594 channels, respectively. Data were analyzed in FlowJo v10.
+ Open protocol
+ Expand
7

HLA-B*27:05 Peptide Dextramer Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stained with LIVE/DEAD Fixable Violet (Thermo Fisher Scientific). Cells were then washed twice and incubated with HLA-B27:05-peptide dextramers as per the manufacturer's protocol (Immudex). Surface markers were identified using anti-CD3–ECD (Beckman Coulter), anti-CD4–APC-eFluor780 (eBioscience), and anti-CD8–PerCP (BD Biosciences). Cells were then washed again and fixed with 1% formaldehyde for a minimum of 1 h. Non-identical HLA-AA2:01-peptide dextramers containing an irrelevant epitope were used as gating controls. Unstained and single-stained cells were used to determine compensation values. Samples were acquired using a CyAn ADP Analyzer (Beckman Dako Cytomation), and data were analyzed using FlowJo software (Tree Star).
+ Open protocol
+ Expand
8

Phenotyping Immune Cell Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
To study cell-surface markers, cells were collected using Versene, a non-enzymatic dissociation buffer (ThermoFisher). Cells were resuspended in the staining buffer (PBS with 4% fetal bovine serum and 2 mM ethylenediaminetetraacetic acid (EDTA)). Cells were then incubated in ice with Fc block reagent (Miltenyi Biotec) for 10 minutes, and stained with the viability dye LIVE/DEAD™ Fixable Violet (ThermoFisher), following the manufacturer's protocol.
Cells were then stained to study the proteins of interest, using the following antibodies: CD16 (APC) (#130-113-389, Miltenyi Biotec), CD14 (APC) (#130-110-520, Miltenyi Biotec), CD163 (FITC) (#33618, BioLegend), CD1a (PE) (#300106, BioLegend), CD80 (PE) (#H12208P, eBioScience), CD83 (APC) (#130-110-504, Miltenyi Biotec), CD86 (APC) (#130-113-569, Miltenyi Biotec), HLA-DR (PE) (#12-9956-42, eBioScience).
After staining, cells were fixed with PBS + 4% paraformaldehyde (Electron Microscopy Sciences) and analyzed within 2 days using a BD FACSCanto™ II Cell Analyzer (BD Biosciences). Data were analyzed with the FlowJo v10 software.
+ Open protocol
+ Expand
9

Isolation of Neutrophils from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was collected from healthy donors between age 18–65 in accordance with the Declaration of Helsinki guidelines and the Institutional Review Board of the University of California Irvine. Red blood cells were separated in 3% Dextran (Sigma Aldrich, St. Louis, MO) PBS and neutrophils were purified from remaining cells by overlay on a Ficoll (GE Healthcare) density gradient and centrifugation at 500xg for 25 min. Remaining RBCs were lysed and neutrophils were re-suspended in RPMI 1640. Purity (>90%) was assessed by flow cytometry using anti-human CD16 and CD66b antibodies (eBioscience, San Diego, CA). Live/Dead fixable violet (Thermo Fisher) was used to gate live cells and positive populations were identified using FMO controls.
+ Open protocol
+ Expand
10

Single-Cell Immune Profiling of Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Only day 9 post-infection samples were sorted for scRNA-seq to obtain a roughly equal proportion of immune and non-immune cells for analysis, although all samples were stained to examine the relative proportions of immune and non-immune cells. Single-cell suspensions were incubated with biotin-conjugated antibodies targeting the following Lineage markers for 30 min at 4 °C in 10% RPMI: CD3e, CD8a, TCRb, B220, NK1.1, Ly6C/G (anti-GR1), CD11b, CD11c, Ter119 (Biolegend). Samples were then washed twice in 10% RPMI and stained with Live/Dead Fixable Violet (ThermoFisher), streptavidin, and anti-CD90 for 30 min at 4 °C in 10% RPMI. Samples were then run on an Aria IIIu cell sorter (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!